Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Neurology. Education
|
May 10, 2024
Curriculum Innovations: Virtual Didactics as a Tool for Harmonizing Education About Rare Topics in Neuroimmunology
John Peters, Jeffrey A Cohen, John R Corboy, et al.
Journal of the Neurological Sciences
|
October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up
Brandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.
Multiple Sclerosis and Related Disorders
|
April 21, 2015
Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study
Fred D Lublin, James D Bowen, John Huddlestone, et al.
Multiple Sclerosis and Related Disorders
|
August 7, 2021
Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls
Enrique Alvarez, Kavita V Nair, Brian D Hoyt, et al.
Neurology. Clinical Practice
|
September 8, 2025
Diagnostic Accuracy of Oligoclonal Bands for CNS Autoimmune Disorders in Acutely Ill Adults
Jarrett Leech, Brian M Sauer, Amiran Baduashvili, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 21, 2025
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial
John R Corboy, Robert J Fox, Gary Cutter, et al.
Neurology. Clinical Practice
|
August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
Brandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Cells
|
July 14, 2023
TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury
Bridget Shafit-Zagardo, Simone Sidoli, James E Goldman, et al.
Neurology
|
September 11, 2013
The American Academy of Neurology's top five Choosing Wisely recommendations
David H Mattson, Robert P Lisak, David E Jones, et al.
JAMA Neurology
|
August 28, 2020
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
Bruce A C Cree, Myla D Goldman, John R Corboy, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Neurology. Education
|
May 10, 2024
Curriculum Innovations: Virtual Didactics as a Tool for Harmonizing Education About Rare Topics in Neuroimmunology
John Peters, Jeffrey A Cohen, John R Corboy, et al.
Journal of the Neurological Sciences
|
October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up
Brandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.
Multiple Sclerosis and Related Disorders
|
April 21, 2015
Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study
Fred D Lublin, James D Bowen, John Huddlestone, et al.
Multiple Sclerosis and Related Disorders
|
August 7, 2021
Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls
Enrique Alvarez, Kavita V Nair, Brian D Hoyt, et al.
Neurology. Clinical Practice
|
September 8, 2025
Diagnostic Accuracy of Oligoclonal Bands for CNS Autoimmune Disorders in Acutely Ill Adults
Jarrett Leech, Brian M Sauer, Amiran Baduashvili, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 21, 2025
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial
John R Corboy, Robert J Fox, Gary Cutter, et al.
Neurology. Clinical Practice
|
August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
Brandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Cells
|
July 14, 2023
TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury
Bridget Shafit-Zagardo, Simone Sidoli, James E Goldman, et al.
Neurology
|
September 11, 2013
The American Academy of Neurology's top five Choosing Wisely recommendations
David H Mattson, Robert P Lisak, David E Jones, et al.
JAMA Neurology
|
August 28, 2020
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
Bruce A C Cree, Myla D Goldman, John R Corboy, et al.
Page
of 9